Treatment-resistant Scopulariopsis brevicaulis infection after filler injection

Acta Dermato-Venereologica

Volumn 89, Issue 6, 2009, Pages 636-638

  Chung, Woon Kyong ^a   Sung, Heungsup ^a   Kim, Mi Na ^a   Lee, Mi Woo ^a   Shin, Jong Hee ^b   Choi, Jee Ho ^a   Moon, Kee Chan ^a   Koh, Jai Kyoung ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B; ASPARTATE AMINOTRANSFERASE; CASPOFUNGIN; CLARITHROMYCIN; COLLAGEN; FILLER; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; MICAFUNGIN; TERBINAFINE; VORICONAZOLE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CONIDIUM; DRUG SENSITIVITY; FACIAL INFECTION; FEMALE; FUNGUS CULTURE; FUNGUS HYPHAE; FUNGUS ISOLATION; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HYALOHYPHOMYCOSIS; INJECTION; LETTER; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCOPULARIOPSIS BREVICAULIS; SEQUENCE HOMOLOGY; SKIN BIOPSY; SKIN NODULE; SKIN ULCER; THERAPY RESISTANCE;

ADULT; ANTIFUNGAL AGENTS; COLLAGEN; COSMETIC TECHNIQUES; DERMATOMYCOSES; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS;

EID: 71949129263     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0713     Document Type: Letter

References (15)

1. Bonifaz A, Cruz-Aguilar P, Ponce RM. Onychomycosis by molds. Report of 78 cases. Eur J Dermatol 2007; 17: 70-72.
2. Clinical and Laboratory Standards Institute. Interpretative criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline. MM18-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
3. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard-second edition. M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
4. Cox NH, Irving B. Cutaneous 'ringworm' lesions of Scopulariopsis brevicaulis. Br J Dermatol 1993; 129: 726-728.
5. Creus L, Umbert P, Torres-Rodriguez JM, López-Gil F. Ulcerous granulomatous cheilitis with lymphatic invasion caused by Scopulariopsis brevicaulis infection. J Am Acad Dermatol 1994; 31: 881-883. (Pubitemid 24336186)
6. Ginarte M, Pereiro M Jr, Fernández-Redondo V, Toribio J. Plantar infection by Scopulariopsis brevicaulis. Dermatology 1996; 193: 149-151.
7. Bruynzeel I, Starink TM. Granulomatous skin infection caused by Scopulariopsis brevicaulis. J Am Acad Dermatol 1998; 39: 365-367. (Pubitemid 28367318)
8. Neglia JP, Hurd DD, Ferrieri P, Snover DC. Invasive Scopulariopsis in the immunocompromised host. Am J Med 1987; 83: 1163-1166.
9. Sellier P, Monsuez JJ, Lacroix C, Feray C, Evans J, Minozzi C, et al. Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient. Clin Infect Dis 2000; 30: 820-823. (Pubitemid 30739529)
10. Steinbach WJ, Schell WA, Miller JL, Perfect JR, Martin PL. Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients. J Infect 2004; 48: 112-116.
11. Aguilar C, Pujol I, Guarro J. In vitro antifungal susceptibilities of Scopulariopsis isolates. Antimicrob Agents Chemother 1999; 43: 1520-1522.
12. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzón A, Rodriguez-Tudela JL. Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents. Antimicrob Agents Chemother 2003; 47: 2339-2341. (Pubitemid 36753597)
13. Oh BJ, Chae MJ, Cho D, Kee SJ, Shin MG, Shin JH, et al. Infection with Scopulariopsis brevicaulis after cosmetic surgery of the face. Korean J Lab Med 2006; 26: 32-35.
14. Erbagci Z, Tuncel AA, Erkilic S, Zer Y. Successful treatment of antifungal- and cryotherapy-resistant subcutaneous hyalohyphomycosis in an immunocompetent case with topical 5% imiquimod cream. Mycopathologia 2005; 159: 521-526. (Pubitemid 40876669)
15. Chung WK, Park GH, Chang SE, Lee MW, Choi JH, Moon KC, et al. A case of Mycobacterium chelonae infection with foreign body granuloma after injection of filler. Korean J Dermatol 2008; 46: 1521-1525.